Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 57, Issue 1, 1983, Pages 133-139

  Mandel, Fred P ^a,b   Geola, Flor L ^a,b   Meldrum, David R ^a,b   Lu, John H K ^a,b   Eggena, Peter ^a,b   Sambhi, Mohinder P ^a,b   Hershman, Jerome M ^a,b   Judd, Howard L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ESTRONE;

BONE; CLINICAL ARTICLE; DRUG EFFICACY; ENDOCRINE SYSTEM; FEMALE GENITAL SYSTEM; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; OSTEOPOROSIS; THERAPY;

ADMINISTRATION, ORAL; CALCIUM; CHOLESTEROL; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGENS, CONJUGATED (USP); ESTRONE; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MENOPAUSE; SEX HORMONE-BINDING GLOBULIN; TRIGLYCERIDES; VAGINA; VAGINAL CREAMS, FOAMS, AND JELLIES;

EQUIDAE;

EID: 0020567867     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-57-1-133     Document Type: Article

References (41)

1. Riggs LA, Hermann H, Yen SSC 1978 Absorption of estrogens from vaginal creams. N Eng J Med 298:195
2. Martin PL, Yen SSC, Burnier AM, Hermann H 1979 Systemic absorption and sustained effects of vaginal estrogen creams. JAMA 242:2699
3. Furuhjelm M, Karlgren E, Carlstrom K 1980 Intravaginal administration of conjugated estrogens in premenopausal and postmenopausal women. Int J Gynaecol Obstet 17:335
4. Deutsch S, Ossowski R, Benjamin I 1981 Comparison between degree of systemic absorption of vaginally and orally administered estrogens at different dose levels in postmenopausal women. Am J Obstet Gynecol 139:967
5. Pasetto N, Piccione E, Pasetto F, Baschieri L, Maturi R 1980 Treatment of patients at risk. Crossover study between natural estrogens. In: Pasetto N, Paoletti R, Ambrus JL (eds) The Menopause and Postmenopause. MTP Press, Lancaster, p 141
6. Geola FL, Frumar AM, Tataryn IV, Lu KH, Hershman JM, Eggena P, Sambhi MP, Judd HL 1980 Biological effects of various doses of conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab 51:620
7. Mandel FP, Geola FL, Lu JKH, Eggena P, Sambhi MP, Hershman J, Judd HL 1982 Biologic effects of various doses of ethinyl estradiol in postmenopausal women. Obstet Gynecol 59:673
8. Crane MB, Harris JJ, Winsor III W 1971 Hypertension, oral contraception agents and conjugated estrogens. Ann Intern Med 74:13
9. Silfverstoipe G, Gustafson A, Samsioe G, Svanborg A 1980 Lipid metabolic studies in oophorectomized women: effects induced by two different estrogens on serum lipids and lipoproteins. Gynecol Obstet Invest 11:161
10. Thom M, Dubiel M, Kakkar VV, Studd JWW 1978 The effect of different regimens of oestrogen on the clotting and fibrinolytic system of the postmenopausal woman. Front Horm Res 5:192
11. Boston Collaborative Drug Surveillance Program 1972 Gallbladder disease, venous disorders, breast tumors: relation to estrogens. N Engl J Med 287:628
12. Nordin BEC, Gallagher JC, Aaron JE, Horsman H 1975 Postmenopausal osteopenia and osteoporosis. In: VanKeep PA, Lauritzen C (eds) Estrogens in the Postmenopause, Frontiers in Hormone Research. Karger, Basel, p 133
13. Gasser A, Celade A, Courvoisier B, Depierre D, Hulma PM, Rinsler M, Williams D 1979 The clinical measurement of urinary total hydroxyproline excretion. Clin Chim Acta 95:487
14. Gallagher JC, Nordin BEC 1975 Effects of estrogen and progesterone therapy on calcium megtabolism in postmenopausal women. Front Horm Res 3:153
15. De Vane GW, Czekala NM, Judd HL, Yen SSC 1975 Circulating gonadotropins, estrogens and androgens in polycystic ovarian disease. Am J Obstet Gynecol 121:496
16. Yen SSC, Llerena O, Little B, Pearson OH 1968 Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man. J Clin Endocrinol Metab 28:1763
17. Yen SSC, Llerna LA, Pearson OH, Littel AS 1970 Disappearance rates of endogenous follicle stimulating hormone in serum following surgical hypophysectomy in man. J Clin Endocrinol Metab 30:325
18. Rosner W 1972 A simplified method for the quantitative determination of testosterone-estradiol-binding globulin activity in human plasma. J Clin Endocrinol Metab 34:983
19. Moore DE, Kawagoe S, Davajan V, Mishell Jr DR, Nakamura R 1978 An in viuo system in man for quantitation of estrogenicity. I. Physiologic changes in binding capacity of serum corticosteroid-binding globulin. Am J Obstet Gynecol 130:475
20. Glinoer D, Fernandez-Deville M, Ermans AM 1979 Use of direct thyroxine-binding globulin measurement in the evaluation of thyroid function. J Endocrinol Invest 1:329
21. Eggena P, Barrett JD, Hidaka H, Chu CL, Thananopavarn C, Golub MS, Sambhi MP 1977 A direct radioimmunoassay for human renin substrate and identification of multiple substrate types in plasma. Circ Res [Suppl 2] 41:37
22. Eggena P, Hidaka H, Barrett JD, Sambhi MP 1978 Multiple forms of human plasma renin substrate. J Clin Invest 26:367
23. Lipid Research Clinic Program 1974 Manual of Laboratory Operations, Vol 1, Lipid and Lipoprotein Analysis. DHEW publication no. 75-628, US Government Printing Office, Washington DC, vol 1
24. Stumpf PG, Maruca J, Santen RJ, Demers LM 1982 Development of a vaginal ring for achieving physiologic levels of 17β-estradiol in hypoestrogenic women. J Clin Endocrinol Metab 54:208
25. Lindsay R, Hart DM, Aitken J, MacDonald EB, Anderson JB, Clarke AC 1976 Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet 1:1038
26. Recker RR, Saville PD, Heaney RP 1977 Effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann Intern Med 87:649
27. Marshall DH, Horsman A, Nordin BEC 1977 The prevention and management of postmenopausal osteoporosis. Acta Obstet Gynecol Scand [Suppl 65] 49
28. Lindsay R, Hart DM, Forrest C, Baird C 1980 Prevention of spinal osteoporosis in oophorectomized women. Lancet 2:1151
29. Weiss NC, Ure CL, Ballard JH, Williams R, Daling JR 1980 Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 303:1195
30. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM 1979 Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis. Obstet Gynecol 53:277
31. Genant HK, Cann CE, Ettinger B, Gordon GS, 1982 Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Int Med 97: 699
32. Stern MP, Brown BW, Haskell WL, Farquhar JW, Wehrle CL, Wood PDS 1976 Cardiovascular risk and use of estrogens or estrogen-progestagen combinations. JAMA 235:811
33. Pfeffer RI 1978 Estrogen use, hypertension and stroke in postmenopausal women. J Chronic Dis 31:389
34. Pfeffer RI, Kurosaki TT, Charlton SK 1976 Estrogen use and stroke risk in postmenopausal women. Am J Epidemiol 103:445
35. Laragh JH, Sealey JE, Ledingham JG, Newton MA 1967 Oral contraceptives: renin, aldosterone, and high blood pressure. JAMA 201:918
36. Boston Collaborative Drug Surveillance Program 1973 Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumors. Lancet 1:1399
37. Small DM 1976 The etiology and pathogenesis of gallstone. Adv Surg 10:63
38. Heuman R, Larsson-Cohn U, Hammar M, Tiselius HG 1979 Effects of postmenopausal ethinylestradiol treatment on gallbladder bile. Maturitas 6:69
39. Aitken JM, Lorimer AR, Hart DM, Lowrie TDV, Smith DA 1971 The effects of oophorectomy and long-term mestranol therapy on the serum lipids of middle-aged women. Clin Sci 41:597
40. Bradley DD, Wingard J, Petitti DB, Krauss RM, Ramcharan S 1978 Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N Engl J Med 299:17
41. Glueck CJ, Scheel D, Fishback J, Steiner P 1972 Estrogen-induced pancreatitis in patients with previously covert familial type V hyperlipidemia. Metabolism 21:657